Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis.

Baldacchino, A., Balfour, D.J.K., Passetti, F., Humphris, G., Matthews, K.·2012·Neuroscience & Biobehavioral Reviews
DOI 10.1016/j.neubiorev.2012.06.006

Cited by (263)

Items 201–263 of 263

  1. Anxiety, Depression, and Emotional Dysregulation Following Prenatal Substance Exposure
    Marvin Rafael Diaz, Elena I. Varlinskaya, Kelcie C. Schatz · 2026 · Advances in experimental medicine and biology
  2. Playing It Safe: A Video Game Probing the Relationship Between Addiction, Gender, and Avoidance
    Zhenhao Shi, An-Li Wang, Daniel D. Langleben · 2016 · The Journal of Clinical Psychiatry
  3. Relationship of neurocognition and treatment retention in subjects on opioid agonist treatment
    Abhishek Ghosh, Devender Kumar Rana, Debasish Basu, Surendra K. Mattoo, Fazle Roub, Ravi Bammidi · 2022 · Journal of Substance Use
  4. Neurocognitive Functions in Opioid Dependence: Comparisons Between Opioid Categories
    Abhishek Ghosh, Alka Shaktan, Abhishek Verma, Ritu Nehra, Debasish Basu, Devender Kumar Rana, Chirag Kamal Ahuja, Manish Modi, Paramjit Singh · 2023 · Journal of Drug Issues
  5. Neurocognitive Dysfunctions in People with Concurrent Cannabis Use and Opioid Dependence: A Cross-Sectional, Controlled Study
    Abhishek Ghosh, Alka Shaktan, Abhishek Verma, Debasish Basu, Devender Kumar Rana, Ritu Nehra, Chirag Kamal Ahuja, Manish Modi, Paramjit Singh · 2024 · Journal of Psychoactive Drugs
  6. The estimated and actual prevalence of dementia among heroin addicts in opioid agonist treatment and comparison with general population, in Slovenia
    Mercedes Lovrečić, Icro Maremmani, Manuel Glauco Carbone, Barbara Lovrečić · 2024 · Heroin addiction and related clinical problems
  7. Evidence for the efficacy of humanizing narratives to promote support for harm-reduction policies in the United States
    Katy Jones, Stephen D. Foster · 2025 · Harm Reduction Journal
  8. Fatalities in Patients with Opioid Use Disorders
    Erin A. Kelty, Agata Chrzanowska, David Brian Preen · 2022 · Springer eBooks
  9. Letter to the Editor: A Novel Therapeutic for Opioid Use Disorder Targeting the Cholinergic System
    Scott J. Moeller, Anissa Abi‐Dargham · 2019 · American Journal on Addictions
  10. Effects of Resilience on Impulsivity, Cognition and Depression during Protracted Withdrawal among Chinese Male Methamphetamine Users
    Siyao Zhou, Wang Ran, Chenhui Peng, Siyu Tong, Lan Hong, Fangfang Cai, Wei Jin, Yile Jiang, Mengjia Li, Xuanping Wang et al. · 2022 · Research Square
  11. Cognitive and Psychological Status of Methadone Maintenance Treatment Patients in Yunnan Province and Its Influencing Factors
    Wen Yang, Xiao Luo, Ke Bi, Yuansen Li, Xuan Fan, Xingyu Liu, Hongwei Hu, Huayou Luo, Mei Hong Zhu, Yu Xu · 2024 · Research Square
  12. Drogas, Trastorno por Uso de Sustancias y Conducción: La intervención de los profesionales que trabajan en adicciones Drugs, Substance Use Disorder and Driving: Intervention of Health Professionals in the Treatment of Addictions
    E. Alvarez, Juan Carlos González-Luque, María Seguí‐Gómez · 2015
  13. Drugs, Substance Use Disorder and Driving: Intervention of Health Professionals in the Treatment of Addictions Drogas, Trastorno por Uso de Sustancias y Conducción: La intervención de los profesionales que trabajan en adicciones
    E. Alvarez, Juan Carlos González-Luque, María Seguí‐Gómez · 2015
  14. Heroin Use, Traumatic Brain Injury, and Schizophrenia Predict Everyday and Social Functioning in Marginally Housed Persons: Direct Effects and Mediation by Neurocognition
    Nena Wang · 2016 · Summit (Simon Fraser University)
  15. Integrating Drug Monitoring into Substance Use Counseling: A Case Report
    Adam Rzetelny · 2015 · Journal of Addiction Research & Therapy
  16. The impact of viral infections on neurocognitive functioning in the context of multiple risk factors: Associations with health care utilization
    Chantelle J. Giesbrecht · 2017 · Summit (Simon Fraser University)
  17. Survey of Pain Therapies in Marfan Syndrome
    Traci J. Speed · 2017 · Journal of Musculoskeletal Disorders and Treatment
  18. Evaluation einer neuropsychologischen Testbatterie an psychiatrischen und psychosomatischen Patienten
    Helga Bartl, Verena Caroline Buschert, Peter Zwanzger, Julia Diemer, Alexander Brunnauer · 2018 · Fortschritte der Neurologie · Psychiatrie
  19. Exploring the understanding and experience of cognitive impairment in chronic opiate users : an interpretative phenomenological analysis.
    Sophie Bates · 2018 · Surrey Research Insight Open Access (The University of Surrey)
  20. Substance Related Cognitive Dysfunction in Aging
    Dora Kanellopoulos, Pablo Sánchez-Barranco Vallejo · 2019 · Clinical handbooks in neuropsychology
  21. Addiction and Mandatory Treatment
    Steve Matthews · 2018 · Routledge eBooks
  22. Cognitive research on addiction in a changing policy landscape
    Andrew Dawson, Wayne Hall, Adrian Carter · 2019 · Elsevier eBooks
  23. Opioid and stimulant use among a sample of corrections-involved drug users : seeking an understanding of high-risk drug decisions within a system of constraint.
    Kirsten Elin Smith · 2019 · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville)
  24. Maintaining Natural Recovery from Prescription Opioid Use Disorder
    Christina Drymon · 2020 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  25. Psychosocial
    J. Megan Ross, Jacqueline C. Duperrouzel, Ileana Pacheco‐Colón, Raúl González · 2020 · The Wiley Encyclopedia of Health Psychology
  26. The Comparison of Working Memory and Reaction Time in Non-Athlete, Athlete and Heroin-Dependent Individuals *
    Haniyeh Soltani, Behrouz Abdoli, Alireza Farsi, Abbas Haghparast · 2020 · فصلنامه علمی و پژوهشی اعتیادپژوهی
  27. Frontal brain functioning and pain: Possible underlying mechanisms of increased pain responses in age- and dementia-related cognitive impairment
    Steffie Bunk · 2021
  28. The Behavioral Role of Mu Opioid Receptors in Glutamatergic Neurons
    Kaitlin C. Reeves · 2021 · IUScholarWorks (Indiana University)
  29. References
    2020 · Elsevier eBooks
  30. Fatalities in Patients with an Opioid Use Disorders
    Erin A. Kelty, Agata Chrzanowska, David Brian Preen · 2022 · Springer eBooks
  31. Cancer Pain Management, Opioid Side Effects, Cognitive Dysfunction
    Kimberson Cochien Tanco, Eduardo D Bruera, Sriram Yennurajalingam · 2013 · Springer eBooks
  32. Other Groups
    H. Thomas Milhorn · 2017 · Springer eBooks
  33. Faculty Opinions recommendation of Neuroimaging impaired response inhibition and salience attribution in human drug addiction: A systematic review.
    Benjamin Y. Hayden · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  34. Neurocognitive Impulsivity in Opiate Users at Different Stages of Abstinence
    Elena Psederska, Jasmin Vassileva · 2022
  35. Opioids and Cognition
    Bethea A. Kleykamp, Shannon B. Clarke, Shauna P. Acquavita · 2023 · Oxford University Press eBooks
  36. Neuropsychological and Psychological Testing in Addiction Medicine
    Benjamin R. Phalin, Amanda K. Janner · 2023 · Elsevier eBooks
  37. References
    2016 · Wiley eBooks
  38. Social and cognitive determinants of medications for opioid use disorder outcomes: A systematic review using a social determinants of health framework
    Alexandra Hernandez‐Vallant, Margo C. Hurlocker · 2024 · Applied Neuropsychology Adult
  39. Opioid Use Disorder
    Christina Spoleti, Gibson George, Padmapriya Marpuri · 2024 · Springer eBooks
  40. Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder
    Alessandro Serretti · 2024 · International Clinical Psychopharmacology
  41. Transdiagnostic factors predicting prescription opioid-use disorder severity: A 12-month prospective study in patients on long-term opioid therapy for chronic pain
    Sara Rodríguez-Espinosa, Ainhoa Coloma‐Carmona, Ana Pérez-Carbonell, José Francisco Román-Quiles, José Luís Carballo · 2024 · Drug and Alcohol Dependence
  42. The potential of non-psychedelic 5-HT2A agents in the treatment of substance use disorders: a narrative review of the clinical literature
    Alejandra Pulido-Saavedra, Anna Borelli, Razi Kitaneh, Mohammad Alrafayia, Laya Jalilian Khave, Melissa Christine Funaro, Marc Nicholas Potenza, Gustavo A. Angarita · 2024 · Expert Opinion on Pharmacotherapy
  43. Substance Use and Memory
    Flávia Zacouteguy Boos, Bruno de Brito Antonio, Beatriz Déo Sorigotto, Marcus Vinicius Alves · 2025 · Springer eBooks
  44. Psychological Distress and Cognitive Function in Women: Exploring Potential Mediation by Use of Opiates, Sleep Aids, or Minor Tranquilizers
    Laura Sampson, Rebecca B. Lawn, Audrey R. Murchland, Jiaxuan Liu, Camille Ianne Marquez, Arielle A. J. Scoglio, Shaili C. Jha, Jennifer A. Sumner, Andrea L. Roberts, Jae Hee Kang et al. · 2025 · Journal of Women s Health
  45. Using explainable machine learning to elucidate social and neurobehavioral risk factors linked to nonmedicinal opioid use in young adults
    Andrea M. Maxwell, Gregory R. Niklason, Sisi Ma, Anna Zilverstand · 2025 · Scientific Reports
  46. Additional file 1 of Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters
    Morgan Scarth, Lars T. Westlye, Ingrid Amalia Havnes, Astrid Bjørnebekk · 2023 · Figshare
  47. Additional file 1 of Effects of resilience on impulsivity, cognition and depression during protracted withdrawal among Chinese male methamphetamine users
    He, He, Zhou, Siyao, Chenhui Peng, Wang Ran, Siyu Tong, Hong, Lan, Fangfang Cai, Wei Jin, Yile Jiang, Li, Mengjia et al. · 2022 · Figshare
  48. Commonalities and differences in trait-like, risky, and utilitarian decision-making styles between abstinent heroin-dependent individuals and their siblings
    Wan-Sen Yan, Yan Lan, Su-Jiao Liu · 2026 · Frontiers in Psychiatry
  49. A HISTORY OF ADOLESCENT OXYCODONE SELF-ADMINISTRATION: NEURAL MECHANISMS UNDERLYING NEUROCOGNITIVE IMPAIRMENTS
    Kristen A. McLaurin, Taylor R Elder, Hailong Li, Brendan J. Veenstra, Kyler J. Nelson, Charles F. Mactutus, Jill R Turner, Rosemarie M. Booze · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Depression trajectories amongst individuals with opioid use disorder treated with extended-release naltrexone during 52-weeks, followed by a 52-week post-treatment period
    Christina L. Redondo, Kristin Klemmetsby Solli, Jūratė Šaltytė Benth, Jon Mordal, Lars Tanum, Bente Margrethe Weimand · 2026 · Journal of Affective Disorders Reports
  51. The association between chronic alcohol, cannabis, and opioids use and autobiographical memory impairments: a systematic review
    Molly Gibson, Zeynab Hemmati, Aldo Alberto Conti, Barbara Dritschel, Alex Baldacchino · 2026 · Frontiers in Psychiatry
  52. Repeated fentanyl administration impairs spatial memory, synaptic plasticity, and induces neuroinflammation in the dorsal hippocampus of rats
    Gabriela Rocha-Botello, Silvia Lorenia Cruz, Emilio J. Galván · 2026 · Neuropharmacology
  53. Mindfulness, Metacognition and Neuropsychological Functioning in Indian Men with Opioid Dependence: Implications for Addiction Recovery and Rehabilitation
    Hemant Kashyap, Lalhmingmawii Khiangte, Nandan Kumar Thakur, Sunita Purty, Kalpana Randhawa, Karuna Kashyap, Khushpreet Kaur, Abhilasha Agarwal, Vinod Kumar Shanwal · 2026 · Annals of Neurosciences
  54. Modélisation des interactions bidirectionnelles entre les processus cognitifs et l'addiction chez le rat
    Mejda Wahab · 2018 · theses.fr (ABES)
  55. Astrocytic disruption and cognitive impairment following sub-acute fentanyl administration in male rats
    Sina Dolatshahi, Hossein Salehi Omran, Amirreza Dowlati Beirami, Maral Hasanzadeh, Amirmahdi Zeynalzadeh, Siavash Parvardeh, Sara Ashtari, Pardis Rabieyan Abianeh, Proushat Shirvani, Paniz Shirvani et al. · 2026 · 3 Biotech
  56. Effect of Overdose-Induced Hypoxia on Neurocognitive Performance in Individuals With Opioid Dependence: A Prospective Multicenter Study
    Sunsha Chamakalayil, Serge Brand, Marc Vogel, Markus Gerber, Kenneth M. Dürsteler · 2026 · ALPHA PSYCHIATRY
  57. Pain and impulsive decision-making: mechanisms, moderators, and intervention pathways
    Dawei Wang, Yicheng Wang, Ziying Lu, Linrui Zhang, Mengmeng Zhou, Yixin Hu · 2026 · Chinese Science Bulletin (Chinese Version)
  58. Medication-Induced Neurotoxicity in Critically Ill Cancer Patients
    Aileen H. Hsi, Monica Elena Loghin · 2026 · Springer eBooks
  59. The relationship between duration of access to intravenous oxycodone self-administration, economic demand for oxycodone, and cognition in rats
    Sydney Dick, Amy Heaton, Aaron D. Claypool, Katherine E. Driver, Elizabeth A. Colley, Viktoria Galbava, Marek Schwendt, Lori A. Knackstedt · 2026 · Psychopharmacology
  60. Cognitive assessment of risk-taking behavior in adults with substance use disorders and internet addiction
    Hrutul Chhag, Chaithanya Leon, Simran Kaur, Yatan Pal Singh Balhara, Ravneet Kaur, Ratna Sharma · 2026 · Indian Journal of Psychiatry
  61. “Cognitive impairments are the worst”: Staff perspectives on challenges in buprenorphine care for people with cognitive and mental health disabilities who inject drugs
    Roberto Abadie · 2026 · Disability and health journal
  62. Pain and Gain: The Opioid Crisis and Financial Adviser Misconduct
    Hugh Hoikwang Kim, Haoran Ma, Xiaonan Ma, Wenting Wang · 2026 · SSRN Electronic Journal
  63. Peripheral inflammation and executive function among community samples across the lifespan: A systematic review and meta-analysis
    Auburn R. Stephenson, Jiana Schnabel, Felicia Petterway, Olivia C. Bishop, Naoise Mac Giollabhui, Lauren B. Alloy · 2026 · Neuroscience & Biobehavioral Reviews